American Bio Medica (ABMC) Stock Price, News & Analysis

Company Overview

American Bio Medica Corp (OTCMKTS:ABMC) is a life sciences company specializing in the development, production and distribution of immunodiagnostic reagents and molecular biological products. Since its founding, the firm has focused on creating high-quality enzyme-linked immunosorbent assay (ELISA) kits, rapid tests and custom antibody services for research, clinical and veterinary applications. Its product portfolio also includes recombinant proteins, peptides and immunoassay buffers designed to support a wide range of life science workflows.

The company’s primary activities encompass assay development and contract manufacturing for diagnostic laboratories, pharmaceutical companies and academic institutions. American Bio Medica’s research and development efforts are aimed at expanding its catalog of assays for infectious diseases, oncology biomarkers, autoimmune markers and environmental testing. By offering both off-the-shelf kits and custom solutions, the firm provides flexibility to clients pursuing novel biomarker discovery or routine screening protocols.

Headquartered in New York, American Bio Medica serves a global customer base through a network of distributors and direct sales channels. Its products are utilized across North America, Europe, Asia-Pacific and Latin America, with support centers in key regions to facilitate regulatory compliance, technical training and after-sales service. The company continually invests in quality management systems and international certifications to meet the exacting standards of clinical laboratories and contract research organizations.

Led by a management team of seasoned life science professionals, American Bio Medica draws on decades of experience in biotechnology, diagnostics and product commercialization. The leadership group oversees a multidisciplinary staff of researchers, manufacturing specialists and field application scientists. Through strategic partnerships and technology collaborations, the company aims to accelerate the translation of scientific discoveries into practical diagnostic tools for the global healthcare and bioresearch markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABMC Stock Analysis - Frequently Asked Questions

How were American Bio Medica's earnings last quarter?

American Bio Medica Corp. (OTCMKTS:ABMC) announced its quarterly earnings results on Monday, May, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $1.04 million for the quarter.

How do I buy shares of American Bio Medica?

Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of American Bio Medica own?

Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include FuelCell Energy (FCEL), OPKO Health (OPK), Canadian Western Bank (CWB), Canopy Growth (CGC), Newmont (NEM), Cortex Pharmaceuticals (RSPI) and V Group (VGID).

Company Calendar

• Last Earnings: 5/14/2018
• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ABMC
• CIK: 896747
• Web: www.abmc.com
• Phone: (518) 758-8158
• Fax: 518-758-8171
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $910 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -2.17